Patents by Inventor Kam Marie Sprott

Kam Marie Sprott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210349099
    Abstract: The present invention relates, in part, to certain cancer biomarkers and use thereof in methods for treating cancer, such as in evaluating and/or predicting patient responses to treatment with a CXCR4 inhibitor optionally in combination with a immunotherapeutic agent, in patients with a cancer such as melanoma, including resectable and unresectable melanoma. The present invention also provides a biomarker expression platform, which is a combination of a set of genes or biomarkers that are correlated with response to a CXCR4 inhibitor in a tumor as well as a normalization gene set. A method and system of using the biomarker expression platform to derive biomarker signatures of anti-tumor response and to test patient samples for predictive biomarker signatures are also disclosed.
    Type: Application
    Filed: November 6, 2018
    Publication date: November 11, 2021
    Inventors: Yan Wang, Simon Paul Fricker, Kam Marie Sprott, Jean S. Campbell, Robert H. Pierce
  • Publication number: 20210025895
    Abstract: The present invention relates, in part, to certain serum biomarkers and use thereof in methods for treating cancer, such as in evaluating and/or in additional methods such as predicting patient responses to treatment with a CXCR4 inhibitor optionally in combination with a immunotherapeutic agent, in patients with a cancer such as melanoma, including resectable and unresectable melanoma.
    Type: Application
    Filed: April 12, 2019
    Publication date: January 28, 2021
    Inventors: Yan Wang, Simon Paul Fricker, Kam Marie Sprott
  • Publication number: 20100099093
    Abstract: This present invention compositions and methods of treating cancer and methods of accessing/monitoring the responsiveness of a cancer cell to a therapeutic compound.
    Type: Application
    Filed: May 14, 2009
    Publication date: April 22, 2010
    Applicant: THE DNA REPAIR COMPANY, INC.
    Inventors: David Weaver, XioaZhe Wang, Kam Marie Sprott
  • Publication number: 20090239229
    Abstract: The present invention provides methods of detecting triple negative breast cancer recurrence using biomarkers.
    Type: Application
    Filed: March 16, 2009
    Publication date: September 24, 2009
    Applicant: DNAR, INC
    Inventors: David Weaver, Kam Marie Sprott, XioaZhe Wang